Michael P. Stansky - 04 Feb 2026 Form 3 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Role: Director
Signature: /s/ Michael P. Stansky
Issuer symbol: TLSI
Transactions as of: 04 Feb 2026
Net transactions value: $0
Form type: 3
Filing time: 11 Feb 2026, 18:50:03 UTC
Next filing: 23 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Stansky Michael P	Director	6272 W. 91ST AVENUE, WESTMINSTER	/s/ Michael P. Stansky	11 Feb 2026	0001424204

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	TLSI	Common Stock						543,232	04 Feb 2026	Direct	F1
holding	TLSI	Common Stock						82,500	04 Feb 2026	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	TLSI	Warrant							04 Feb 2026	Common Stock	827,500	$11.50	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The securities reported herein were acquired by the Reporting Person prior to the Reporting Person becoming a director of the issuer. The Reporting Person was appointed as a director of the Issuer effective February 4, 2026.
F2	The securities reported herein are owned by Skyview Investments LLC. Mr. Stansky serves as managing member of Skyview Investments LLC (and in such capacity may be deemed to beneficially own the securities reported herein). Voting and dispositive power over the securities owned by Skyview Investments LLC is exercised in his capacity as managing member.